Dealing with cancer screening in the COVID-19 era
| Autor: | Luciana Castro Garcia Landeiro, Diego Lopes Paim Miranda, Caenna Corrêa E Correia, Angélica Nogueira-Rodrigues, Gabriel Souza Fontes Ayres, Ronniel Morais Albuquerque, Thales Pardini Fagundes |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Adult
Male medicine.medical_specialty Medicine (General) Colorectal cancer Uterine Cervical Neoplasms Coronavirus infections Breast cancer R5-920 Neoplasms Cancer screening medicine Humans Mass Screening Papillomavirus Vaccines Pap test Pandemics Mass screening Cervical cancer Cervical screening medicine.diagnostic_test SARS-CoV-2 business.industry Papillomavirus Infections COVID-19 Prostatic Neoplasms General Medicine Prostate-Specific Antigen medicine.disease Prostate cancer screening Family medicine Early detection of cancer Female Colorectal Neoplasms business |
| Zdroj: | Revista da Associação Médica Brasileira, Vol 67, Iss suppl 1, Pp 86-90 (2021) Revista da Associação Médica Brasileira v.67 suppl.1 2021 Revista da Associação Médica Brasileira Associação Médica Brasileira (AMB) instacron:AMB Revista da Associação Médica Brasileira, Volume: 67 Supplement 1, Pages: 86-90, Published: 13 AUG 2021 |
| ISSN: | 1806-9282 |
| Popis: | SUMMARY OBJECTIVE: This article aims to alert health professionals for cancer screening in the face of the possibility of new waves of disease. METHODS: A narrative review was conducted through a search in MEDLINE, Lilacs, Chinese Biomedical Literature Database, and international medical societies publications. RESULTS: Breast cancer: in high-risk patients (confirmed familial cancer syndrome or with high-risk tools scores), clinicians should act according to usual recommendations; in average-risk individuals, consider screening with mammography with a longer time span (maximum of two years). Cervical cancer: women turning 25 years old who have already been immunized and with no previous Pap test can have the test postponed during the pandemic; if there is no previous dose of Human Papillomavirus vaccination, initiation of screening should be recommended following a more rigid approach for COVID prevention; in women over 30 years of age who have never participated in cervical screening, the first screening exam is also essential. Colorectal cancer: if the individual is at elevated risk for familial cancer, the screening with colonoscopy according to usual recommendations should be supported; if at average risk consider screening with Fecal Occult Blood Test. Prostate cancer: there is a trend to postpone routine prostate cancer screening until the pandemic subsides. CONCLUSIONS: The decision to keep cancer screening must be discussed and individualized, considering the possibility of new waves of COVID-19. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|